Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

NCT01496118 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: panobinostat
DRUG: carfilzomib

Sponsor

SCRI Development Innovations, LLC

Collaborators

[object Object]
[object Object]